Genomics BioSci & Tech. Co.,Ltd. (TPEX:4195)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.30
-0.55 (-2.05%)
Sep 17, 2025, 1:55 PM CST

Genomics BioSci & Tech. Statistics

Total Valuation

TPEX:4195 has a market cap or net worth of TWD 1.95 billion. The enterprise value is 2.44 billion.

Market Cap1.95B
Enterprise Value 2.44B

Important Dates

The next estimated earnings date is Thursday, November 13, 2025.

Earnings Date Nov 13, 2025
Ex-Dividend Date n/a

Share Statistics

TPEX:4195 has 72.45 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class 72.45M
Shares Outstanding 72.45M
Shares Change (YoY) +0.02%
Shares Change (QoQ) n/a
Owned by Insiders (%) 9.96%
Owned by Institutions (%) 4.60%
Float 53.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.45
PB Ratio 3.24
P/TBV Ratio 3.75
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -13.66
EV / Sales 4.33
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -9.39

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.99.

Current Ratio 1.35
Quick Ratio 0.79
Debt / Equity 0.99
Debt / EBITDA n/a
Debt / FCF -2.28
Interest Coverage -10.36

Financial Efficiency

Return on equity (ROE) is -28.95% and return on invested capital (ROIC) is -6.05%.

Return on Equity (ROE) -28.95%
Return on Assets (ROA) -5.46%
Return on Invested Capital (ROIC) -6.05%
Return on Capital Employed (ROCE) -12.44%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.43
Inventory Turnover 2.80

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +47.25% in the last 52 weeks. The beta is 0.19, so TPEX:4195's price volatility has been lower than the market average.

Beta (5Y) 0.19
52-Week Price Change +47.25%
50-Day Moving Average 21.55
200-Day Moving Average 19.23
Relative Strength Index (RSI) 65.95
Average Volume (20 Days) 826,971

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:4195 had revenue of TWD 563.09 million and -178.49 million in losses. Loss per share was -2.46.

Revenue563.09M
Gross Profit 163.10M
Operating Income -115.33M
Pretax Income -202.74M
Net Income -178.49M
EBITDA -57.70M
EBIT -115.33M
Loss Per Share -2.46
Full Income Statement

Balance Sheet

The company has 177.23 million in cash and 592.47 million in debt, giving a net cash position of -415.24 million or -5.73 per share.

Cash & Cash Equivalents 177.23M
Total Debt 592.47M
Net Cash -415.24M
Net Cash Per Share -5.73
Equity (Book Value) 601.23M
Book Value Per Share 7.23
Working Capital 151.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -140.25 million and capital expenditures -119.30 million, giving a free cash flow of -259.54 million.

Operating Cash Flow -140.25M
Capital Expenditures -119.30M
Free Cash Flow -259.54M
FCF Per Share -3.58
Full Cash Flow Statement

Margins

Gross margin is 28.96%, with operating and profit margins of -20.48% and -31.70%.

Gross Margin 28.96%
Operating Margin -20.48%
Pretax Margin -36.01%
Profit Margin -31.70%
EBITDA Margin -10.25%
EBIT Margin -20.48%
FCF Margin n/a

Dividends & Yields

TPEX:4195 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.02%
Shareholder Yield n/a
Earnings Yield -9.18%
FCF Yield -13.34%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.

Last Split Date Aug 8, 2023
Split Type Forward
Split Ratio 1.02

Scores

TPEX:4195 has an Altman Z-Score of 1.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.13
Piotroski F-Score 2